The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.
 
Veronique Minard-Colin
No Relationships to Disclose
 
Anne Auperin
No Relationships to Disclose
 
Marta Pillon
No Relationships to Disclose
 
Amos Burke
No Relationships to Disclose
 
James Robert Anderson
Employment - Merck
Stock and Other Ownership Interests - Merck
Consulting or Advisory Role - Amgen; Merck
 
Donald A. Barkauskas
Patents, Royalties, Other Intellectual Property - U.S. patent based on Ph.D. research in glioblastoma (I)
 
Keith Wheatley
No Relationships to Disclose
 
Rafael Delgado
No Relationships to Disclose
 
Sarah Alexander
No Relationships to Disclose
 
Anne Uyttebroeck
No Relationships to Disclose
 
Catherine Bollard
No Relationships to Disclose
 
Jozsef Zsiros
No Relationships to Disclose
 
Monika Csoka
No Relationships to Disclose
 
Gisele Goma
No Relationships to Disclose
 
Anne Tulard
No Relationships to Disclose
 
Catherine Patte
No Relationships to Disclose
 
Thomas G. Gross
No Relationships to Disclose